Papers - Tasaka Sadatomo
-
細菌性肺炎
當麻景章，田坂定智
カレントテラピー 40 1048 - 1053 2022
-
急性呼吸窮迫症候群（ARDS）
田坂定智
日本医事新報 5141 38 - 38 2022
-
呼吸数，測ってますか？
田坂定智
Medical Practice 39 ( 12 ) 1903 - 1903 2022
-
急性間質性肺炎．
田坂定智
弦間昭彦 編．最新ガイドラインに基づく呼吸器疾患診療指針2023-2024 149 - 154 2022
-
多様化するタバコ問題の現状
田坂定智
モダンメディア 68 ( 12 ) 509 - 514 2022
-
Pathophysiology of ARDS: What is the current understanding of pathophysiology of ARDS? ed., Tasaka S. Acute Respiratory Distress Syndrome. Advances in Diagnostic Tools and Disease Management.
Tasaka S.
Springer Nature 33 - 52 2022
-
Prospective analysis of factors precluding the initiation of durvalumab from an interim analysis of a phase II trial of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small cell lung cancer in Japan (SAMURAI study).
Tanzawa S, Makiguchi T, Tasaka S, Inaba M, Ochiai R, Nakamura J, Inoue K, Kishikawa T, Nakashima M, Fujiwara K, Kohyama T, Ishida H, Kuyama S, Miyazawa N, Nakamura T, Miyawaki H, Oda N, Ishikawa N, Morinaga R, Kusaka K, Miyamoto Y, Yokoyama T, Matsumoto C, Tsuda T, Ushijima S, Shibata K, Shibayama T, Bessho A, Kaira K, Misumi T, Shiraishi K, Matsutani N, Seki N
Therapeutic advances in medical oncology 14 17588359221116603 2022
-
Epidemiological investigation of the factors affecting the COVID-19 case fatality rate
Tsuchiya Junichiro, Saito Norihiro, Itoga Masamichi, Tasaka Sadatomo, Kayaba Hiroyuki
Hirosaki Medical Journal 72 ( 1-4 ) 34 - 42 2022
-
How to improve lung auscultation in daily practice
Cho Sumito, Tasaka Sadatomo
The Journal of the Japan Society for Respiratory Care and Rehabilitation 30 ( 1 ) 23 - 23 2021.12
-
Characteristics of central nervous system progression in non-small cell lung cancer treated with crizotinib or alectinib.
Sakamoto H, Yanagitani N, Manabe R, Tsugitomi R, Ogusu S, Tozuka T, Yoshida H, Amino Y, Ariyasu R, Uchibori K, Kitazono S, Tasaka S, Nishio M
Cancer reports (Hoboken, N.J.) 4 ( 6 ) e1414 2021.12
-
Immune-mediated thrombocytopenia induced with durvalumab after chemoradiotherapy in a non-small cell lung cancer patient: A case report.
Makiguchi T, Tanaka H, Kamata K, Taima K, Kurose A, Tasaka S
Thoracic cancer 12 ( 20 ) 2811 - 2814 2021.10
-
Immune-mediated thrombocytopenia induced with durvalumab after chemoradiotherapy in a non-small cell lung cancer patient: A case report.
Tomonori Makiguchi, Hisashi Tanaka, Kosuke Kamata, Kageaki Taima, Akira Kurose, Sadatomo Tasaka
Thoracic cancer 12 ( 20 ) 2811 - 2814 2021.8
-
本邦で検証が進む新型たばこ関連肺障害
田坂 定智
週刊医学界新聞 ( 第3429号 ) 2021.7
-
The relationship between evolving sarcopenia and efficacy of immune checkpoint inhibitor in non-small cell lung cancer patients.
Makiguchi T, Tanaka H, Taima K, Tatsuo S, Iida S, Kakeda S, Tasaka S.
JCSM Clin Rep 2021.7
-
The relationship between evolving sarcopenia and efficacy of immune checkpoint inhibitor in non-small cell lung cancer patients
2021.7
-
特集 内科疾患の診断基準・病型分類・重症度 第1章 呼吸器 急性呼吸窮迫症候群(ARDS)
田坂 定智
内科 127 ( 4 ) 524 - 526 2021.4
-
疾患と検査値の推移 急性呼吸窮迫症候群(ARDS)
田坂 定智
検査と技術 49 ( 4 ) 508 - 514 2021.4
-
6. Diagnosis and Treatment of ARDS
Tasaka Sadatomo
Nihon Naika Gakkai Zasshi 110 ( Suppl ) 107b - 108a 2021.2
-
Procalcitonin expression in patients with large cell neuroendocrine carcinoma of the lung.
Masamichi Itoga, Hisashi Tanaka, Kageaki Taima, Yoshiko Ishioka, Hiroaki Sakamoto, Shingo Takanashi, Akira Kurose, Sadatomo Tasaka
BMC research notes 14 ( 1 ) 25 - 25 2021.1
-
Activity and bioavailability of tepotinib for leptomeningeal metastasis of NSCLC with MET exon 14 skipping mutation.
Hisashi Tanaka, Kageaki Taima, Tomonori Makiguchi, Junichi Nakagawa, Takenori Niioka, Sadatomo Tasaka
Cancer communications (London, England) 41 ( 1 ) 83 - 87 2021.1